FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073447615> ?p ?o ?g. }

• W2073447615 endingPage "14" @default.
• W2073447615 startingPage "6" @default.
• W2073447615 abstract "Metabolism in tumors deviates significantly from that of normal tissues. Increasingly, the underlying aberrant metabolic pathways are being considered as novel targets for cancer therapy. Denoted “metabolic targeting”, small molecule drugs are under investigation for focused inhibition of key metabolic steps that are utilized by tumors, since such inhibitors should harbor minimal toxicity towards surrounding normal tissues. This review will examine the primary biochemical pathways that tumors harness to enhance their bioenergetic capacity, which in turn, help their rapid proliferation and metastasis within the host. It is hoped that “metabolite-mimetic” drugs can be utilized to interfere with metabolic flux pathways active within the tumor, and across tumor-microenvironment boundary. In fact, the major pathways of mammalian metabolism, i.e., the carbohydrate, amino-acid, and fatty-acid metabolic pathways have been examined as putative targets for drug development, with some drug candidates advancing to phase II/III stages. In this regard, glucose metabolism, i.e., the glycolytic pathway - that predominates the bio-energetic flux in tumors, and the associated mitochondrial metabolism have received the most attention as suitable “druggable” targets, focused either at the pathway enzymes or at the plasma-membrane-bound metabolite transporters. Outlined in this review are pre-clinical studies that have led to the discovery of promising drug candidates to target tumor-metabolic flux, and ensuing patents, with descriptions of the biochemical rationale for the combinatorial strategy of a particular metabolic pathway-drug candidate pair. Keywords: Metabolism, glycolysis, tumor, mitochondria, metabolic targeting, metabolite-mimetics, oxidative phosphorylation, glucose transporters, positron emission tomography, tumori-genesis, UDP-Gal, phospho-fructokinase, aldolase, nitrosoureas, cisplatins, taxanes, IGFR, GAPDH, PDK, pyruvate dehydrogenase complex, PDH, dichloroacetate, diRuthenium, HIF-1, Drosophila ultrabithorax gene, ARNT, technetium, SMMRs, malonyl-CoA decarboxylase, fatty acid synthase, UCP, glyco-randomization, thioredoxin, Tavocept, dimesna, BNP7787" @default.
• W2073447615 created "2016-06-24" @default.
• W2073447615 creator A5030723056 @default.
• W2073447615 date "2011-01-01" @default.
• W2073447615 modified "2023-09-23" @default.
• W2073447615 title "Metabolic Targeting of Malignant Tumors: Small-Molecule Inhibitors of Bioenergetic Flux" @default.
• W2073447615 cites W1967482096 @default.
• W2073447615 cites W1970312353 @default.
• W2073447615 cites W1970558444 @default.
• W2073447615 cites W1970991025 @default.
• W2073447615 cites W1975082755 @default.
• W2073447615 cites W1983203634 @default.
• W2073447615 cites W2003322497 @default.
• W2073447615 cites W2017650892 @default.
• W2073447615 cites W2018971639 @default.
• W2073447615 cites W2020895105 @default.
• W2073447615 cites W2021476435 @default.
• W2073447615 cites W2023177835 @default.
• W2073447615 cites W2025621335 @default.
• W2073447615 cites W2031628684 @default.
• W2073447615 cites W2032817339 @default.
• W2073447615 cites W2062538700 @default.
• W2073447615 cites W2068484236 @default.
• W2073447615 cites W2072451938 @default.
• W2073447615 cites W2077230187 @default.
• W2073447615 cites W2090846942 @default.
• W2073447615 cites W2091811407 @default.
• W2073447615 cites W2097259163 @default.
• W2073447615 cites W2099616702 @default.
• W2073447615 cites W2102322990 @default.
• W2073447615 cites W2104824311 @default.
• W2073447615 cites W2114005496 @default.
• W2073447615 cites W2117272838 @default.
• W2073447615 cites W2130503287 @default.
• W2073447615 cites W2139807366 @default.
• W2073447615 cites W2152720583 @default.
• W2073447615 cites W2156687584 @default.
• W2073447615 cites W2159194061 @default.
• W2073447615 cites W2184036762 @default.
• W2073447615 cites W2409153565 @default.
• W2073447615 cites W64243666 @default.
• W2073447615 cites W94071839 @default.
• W2073447615 cites W2023103376 @default.
• W2073447615 cites W335920212 @default.
• W2073447615 doi "https://doi.org/10.2174/157489211793980114" @default.
• W2073447615 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3385861" @default.
• W2073447615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21110820" @default.
• W2073447615 hasPublicationYear "2011" @default.
• W2073447615 type Work @default.
• W2073447615 sameAs 2073447615 @default.
• W2073447615 citedByCount "15" @default.
• W2073447615 countsByYear W20734476152012 @default.
• W2073447615 countsByYear W20734476152013 @default.
• W2073447615 countsByYear W20734476152014 @default.
• W2073447615 countsByYear W20734476152015 @default.
• W2073447615 countsByYear W20734476152018 @default.
• W2073447615 countsByYear W20734476152019 @default.
• W2073447615 countsByYear W20734476152020 @default.
• W2073447615 countsByYear W20734476152021 @default.
• W2073447615 countsByYear W20734476152022 @default.
• W2073447615 crossrefType "journal-article" @default.
• W2073447615 hasAuthorship W2073447615A5030723056 @default.
• W2073447615 hasBestOaLocation W20734476152 @default.
• W2073447615 hasConcept C104317684 @default.
• W2073447615 hasConcept C10679952 @default.
• W2073447615 hasConcept C160941953 @default.
• W2073447615 hasConcept C178790620 @default.
• W2073447615 hasConcept C185592680 @default.
• W2073447615 hasConcept C192989942 @default.
• W2073447615 hasConcept C20251656 @default.
• W2073447615 hasConcept C2777477808 @default.
• W2073447615 hasConcept C28859421 @default.
• W2073447615 hasConcept C55493867 @default.
• W2073447615 hasConcept C57600042 @default.
• W2073447615 hasConcept C62231903 @default.
• W2073447615 hasConcept C68709404 @default.
• W2073447615 hasConcept C74187038 @default.
• W2073447615 hasConcept C86803240 @default.
• W2073447615 hasConceptScore W2073447615C104317684 @default.
• W2073447615 hasConceptScore W2073447615C10679952 @default.
• W2073447615 hasConceptScore W2073447615C160941953 @default.
• W2073447615 hasConceptScore W2073447615C178790620 @default.
• W2073447615 hasConceptScore W2073447615C185592680 @default.
• W2073447615 hasConceptScore W2073447615C192989942 @default.
• W2073447615 hasConceptScore W2073447615C20251656 @default.
• W2073447615 hasConceptScore W2073447615C2777477808 @default.
• W2073447615 hasConceptScore W2073447615C28859421 @default.
• W2073447615 hasConceptScore W2073447615C55493867 @default.
• W2073447615 hasConceptScore W2073447615C57600042 @default.
• W2073447615 hasConceptScore W2073447615C62231903 @default.
• W2073447615 hasConceptScore W2073447615C68709404 @default.
• W2073447615 hasConceptScore W2073447615C74187038 @default.
• W2073447615 hasConceptScore W2073447615C86803240 @default.
• W2073447615 hasIssue "1" @default.
• W2073447615 hasLocation W20734476151 @default.
• W2073447615 hasLocation W20734476152 @default.
• W2073447615 hasLocation W20734476153 @default.
• W2073447615 hasLocation W20734476154 @default.

• next